News: Clinical News
Latest in Clinical News
Sanofi-aventis has announced that its investigational once-daily oral drug teriflunomide, for the treatment of relapsing multiple sclerosis (RMS), has met the primary endpoint in its Phase III trial.
02 September 2010
Trius Initiates Clinical Study of Skin Infection Drug
02 September 2010
02 September 2010
US Awards Biothreat Antibiotic Contract
01 September 2010
01 September 2010
BTG Swoops for Nycomed Digoxin Antivenoms
01 September 2010
01 September 2010
BioMarin Receives Orphan Drug Designation for Pompe Disease Drug
01 September 2010
01 September 2010
Portola Announces Positive Results for Anti-Platelet Drug
01 September 2010
01 September 2010
FDA Slow Tracks Genetech Antibody-Drug Conjugate
31 August 2010
31 August 2010
Shire's Gaucher Drug Approved in Europe
31 August 2010
31 August 2010
Plexxikon Announces Positive Results of Melanoma Drug Study
31 August 2010
31 August 2010
Pharmasset Initiates Hepatitis C Drug Trial
31 August 2010
31 August 2010
